207 related articles for article (PubMed ID: 36977926)
1. The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT.
Tournilhac O; van Gelder M; Eikema DJ; Zinger N; Dreger P; Bornhäuser M; Vucinic V; Scheid C; Cornelissen JJ; Schroeder T; Jindra P; Sengeloev H; Nguyen Quoc S; Stelljes M; Blau IW; Mayer J; Paneesha S; Chevallier P; Forcade E; Kröger N; Blaise D; Gribben J; Nielsen B; Johansson JE; Kyriakou C; Beguin Y; Pioltelli P; Sampol A; McLornan DP; Schetelig J; Hayden PJ; Yakoub-Agha I
Bone Marrow Transplant; 2023 Jun; 58(6):621-624. PubMed ID: 36977926
[TBL] [Abstract][Full Text] [Related]
2. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT.
Gilleece MH; Labopin M; Savani BN; Yakoub-Agha I; Socié G; Gedde-Dahl T; Blaise D; Byrne JL; Craddock C; Cornelissen JJ; Arcese W; Forcade E; Crawley C; Polge E; Mohty M; Nagler A
Leukemia; 2020 Jan; 34(1):87-99. PubMed ID: 31363160
[TBL] [Abstract][Full Text] [Related]
4. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J;
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):667-675.e2. PubMed ID: 28694085
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM; Nampoothiri RV; Chen C; Pasic I; Al-Shaibani Z; Lam W; Law AD; Michelis FV; Kim DDH; Gerbitz A; Lipton J; Kumar R; Mattsson J; Viswabandya A
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):230-237. PubMed ID: 34856195
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?
Delgado J; Milligan DW; Dreger P
Blood; 2009 Sep; 114(13):2581-8. PubMed ID: 19641189
[TBL] [Abstract][Full Text] [Related]
7. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Dholaria B; Finke J; Brecht A; Schanz U; Niittyvuopio R; Neubauer A; Bornhäuser M; Santarone S; Beelen D; Shimoni A; Rösler W; Giebel S; Savani BN; Mohty M
Br J Haematol; 2019 Sep; 186(5):767-776. PubMed ID: 31115916
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
van Gorkom G; van Gelder M; Eikema DJ; Blok HJ; van Lint MT; Koc Y; Ciceri F; Beelen D; Chevallier P; Selleslag D; Blaise D; Foá R; Corradini P; Castagna L; Moreno C; Solano C; Müller LP; Tischer J; Hilgendorf I; Hallek M; Bittenbring J; Theobald M; Schetelig J; Kröger N; ;
Bone Marrow Transplant; 2018 Mar; 53(3):255-263. PubMed ID: 29255169
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse.
Hahn M; Böttcher S; Dietrich S; Hegenbart U; Rieger M; Stadtherr P; Bondong A; Schulz R; Ritgen M; Schmitt T; Tran TH; Görner M; Herth I; Luft T; Schönland S; Witzens-Harig M; Zenz T; Kneba M; Ho AD; Dreger P
Bone Marrow Transplant; 2015 Oct; 50(10):1279-85. PubMed ID: 26146810
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens.
Kharfan-Dabaja MA; Bazarbachi A
Cancer Control; 2012 Jan; 19(1):68-75. PubMed ID: 22143063
[TBL] [Abstract][Full Text] [Related]
12. Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.
Kharfan-Dabaja MA; Pidala J; Kumar A; Terasawa T; Djulbegovic B
Bone Marrow Transplant; 2012 Sep; 47(9):1164-70. PubMed ID: 22562081
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Onida F; de Wreede LC; van Biezen A; Eikema DJ; Byrne JL; Iori AP; Schots R; Jungova A; Schetelig J; Finke J; Veelken H; Johansson JE; Craddock C; Stelljes M; Theobald M; Holler E; Schanz U; Schaap N; Bittenbring J; Olavarria E; Chalandon Y; Kröger N
Br J Haematol; 2017 Jun; 177(5):759-765. PubMed ID: 28369779
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP).
Michallet M; Thiébaut A; Dreger P; Remes K; Milpied N; Santini G; Hamon M; Björkstrand B; Kimby E; Belhabri A; Tanguy ML; Apperley JF
Br J Haematol; 2000 Mar; 108(3):595-601. PubMed ID: 10759719
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Ortí G; Gras L; Zinger N; Finazzi MC; Sockel K; Robin M; Forcade E; Avenoso D; Kröger N; Finke J; Radujkovic A; Hunault-Berger M; Schroyens W; Zuckerman T; Bourhis JH; Chalandon Y; Bloor A; Schots R; de Wreede LC; Drozd-Sokolowska J; Raj K; Polverelli N; Czerw T; Hernández-Boluda JC; McLornan D; Yakoub-Agha I
Am J Hematol; 2023 Apr; 98(4):628-638. PubMed ID: 36606718
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT.
Shimoni A; Robin M; Iacobelli S; Beelen D; Mufti GJ; Ciceri F; Bethge W; Volin L; Blaise D; Ganser A; Luft T; Chevallier P; Schwerdtfeger R; Koster L; de Witte T; Kröger N; Nagler A; Yakoub-Agha I
Br J Haematol; 2021 Nov; 195(3):417-428. PubMed ID: 34514596
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT.
Gutiérrez-García G; Martínez C; Boumendil A; Finel H; Malladi R; Afanasyev B; Tsoulkani A; Wilson KMO; Bloor A; Nikoloudis M; Richardson D; López-Corral L; Castagna L; Cornelissen J; Giltat A; Collin M; Fanin R; Bonifazi F; Robinson S; Montoto S; Peggs KS; Sureda A
Br J Haematol; 2022 Feb; 196(4):1018-1030. PubMed ID: 34750806
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Hill BT; Ahn KW; Hu ZH; Aljurf M; Beitinjaneh A; Cahn JY; Cerny J; Kharfan-Dabaja MA; Ganguly S; Ghosh N; Grunwald MR; Inamoto Y; Kindwall-Keller T; Nishihori T; Olsson RF; Saad A; Seftel M; Seo S; Szer J; Tallman M; Ustun C; Wiernik PH; Maziarz RT; Kalaycio M; Alyea E; Popat U; Sobecks R; Saber W
Biol Blood Marrow Transplant; 2018 Mar; 24(3):581-586. PubMed ID: 29032274
[TBL] [Abstract][Full Text] [Related]
20. Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Labopin M; Houhou M; Caillot D; Finke J; Blaise D; Fegueux N; Ethell M; Cornelissen JJ; Forcade E; Yakoub-Agha I; Lussana F; Maertens J; Bourhis JH; Jindra P; Gorin NC; Nagler A; Mohty M
Bone Marrow Transplant; 2023 Apr; 58(4):393-400. PubMed ID: 36611097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
